Santersus AG Congratulates OrganOx on Strategic Acquisition by Terumo Corporation — Underscores Ongoing Collaboration in Donor Liver Perfusion
Zurich, Switzerland — September 13, 2025 — Santersus AG congratulates its alliance partner OrganOx Ltd on the company’s acquisition by Terumo Corporation in a transaction valued at up to $1.5 billion — a major milestone in the evolution of global transplant technologies. OrganOx is a leader in normothermic machine perfusion (NMP) for liver transplantation, with …